Results 1 to 10 of about 1,700,231 (391)

China Anti-Cancer Association guideline for diagnosis and treatment of neuroendocrine neoplasm (2022 edition) [PDF]

open access: yesZhongguo aizheng zazhi, 2022
Neuroendocrine neoplasm (NEN) is a kind of rare tumor that originated from peptidergic neurons and neuroendocrine cells, which has neuroendocrine differentiation and expresses neuroendocrine markers.
Society of Neuroendocrine Neoplasm of China Anti-Cancer Association
doaj   +1 more source

Clinical significance of diagnostic laparoscopy on precision staging in advanced gastric cancer [PDF]

open access: yesWaike lilun yu shijian, 2022
Gastric cancer is the leading cause of cancer-related deaths in human. More than 70% patients present with advanced gastric cancer or with metastasis in clinic.
NIE Mingming, ZHU Zhenggang
doaj   +1 more source

Effect of Osimertinib in Combination With Chemotherapy and Bevacizumab for Untreated Epidermal Growth Factor Receptor–Mutated Advanced Non-Small-Cell Lung Cancer: Case Report

open access: yesFrontiers in Pharmacology, 2021
Introduction: Osimertinib is an oral, third-generation, irreversible epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) that selectively inhibits both EGFR-TKI–sensitizing and EGFR T790M resistance mutations.
Haifeng Qin   +5 more
doaj   +1 more source

Solid pseudopapillary neoplasm of the pancreas

open access: yesWorld Journal of Hepatology, 2021
Solid pseudopapillary neoplasms are rare. This article reviews the clinical and pathologic features of solid pseudopapillary neoplasm of the pancreas, including the epidemiology, cytology, molecular pathology, differential diagnosis, treatment, and ...
A. Omiyale
semanticscholar   +1 more source

MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms

open access: yesScientific Reports, 2023
MALAT1 long non-coding RNA has oncogenic roles but has been poorly studied in indolent B-cell neoplasms. Here, MALAT1 expression was analyzed using RNA-seq, microarrays or qRT-PCR in primary samples from clinico-biological subtypes of chronic lymphocytic
Elena María Fernández-Garnacho   +17 more
doaj   +1 more source

Pancreatic Solid Pseudopapillary Neoplasm: Key Pathologic and Genetic Features.

open access: yesArchives of Pathology & Laboratory Medicine, 2020
CONTEXT.— Solid pseudopapillary neoplasm of the pancreas is a low-grade malignant tumor generally associated with a good prognosis. Solid pseudopapillary neoplasms show peculiar morphologic features, but sometimes the differential diagnosis with other ...
S. Rosa, M. Bongiovanni
semanticscholar   +1 more source

Neuroendocrine neoplasm update: toward universal nomenclature.

open access: yesEndocrine-Related Cancer, 2020
Neuroendocrine neoplasia is described in almost every tissue, either in the pure endocrine organs, the nerve structures or in the so-called diffuse neuroendocrine system. The current nomenclature contains time-honored widely accepted definitions; however,
G. Rindi, F. Inzani
semanticscholar   +1 more source

Appendiceal Neoplasms [PDF]

open access: yesClinics in Colon and Rectal Surgery, 2018
AbstractAppendiceal neoplasms are identified in 0.9 to 1.4% of appendiceal specimens, and the incidence is increasing. It has long been professed that neuroendocrine tumors (formerly carcinoids) are the most common neoplastic process of the appendix; recent data, however, has suggested a shift in epidemiology.
Quinton M, Hatch, Erin W, Gilbert
openaire   +2 more sources

Sex differences in solid pseudopapillary neoplasm of the pancreas: A population‐based study

open access: yesCancer Medicine, 2020
Solid pseudopapillary neoplasm (SPN) of the pancreas is a rare tumor. This study aims to examine the clinicopathological features and surgical treatments of SPN and compare the clinical behavior and prognosis between men and women with SPN.
Jiali Wu   +6 more
semanticscholar   +1 more source

Tagraxofusp in Blastic Plasmacytoid Dendritic‐Cell Neoplasm

open access: yesNew England Journal of Medicine, 2019
Background Blastic plasmacytoid dendritic‐cell neoplasm (BPDCN) is an aggressive hematologic cancer that is caused by transformed plasmacytoid dendritic cells that overexpress interleukin‐3 receptor subunit alpha (IL3RA or CD123). Tagraxofusp (SL‐401) is
N. Pemmaraju   +17 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy